Almirall and HitGen partner for atopic dermatitis drug discovery

Dermatology company Almirall partnered with discovery company HitGen to identify oral small molecules against undisclosed targets for moderate-to-severe atopic dermatitis.

Almirall S.A. (Madrid:ALM) will provide screening material and HitGen Ltd. (Chengdu, China) will use its DNA-encoded chemical libraries to conduct screening and early testing of lead compounds...